Clinical Trials Browser

Phase 2 × peginterferon alfa-2a × Gastrointestinal × Clear all

NCT04798612 2023-08-18

IPOS

Phase 2 Unknown

Gastrointestinal

Colonic Neoplasms

NCT02576964 2016-11-02

A Study of Capecitabine (Xeloda) and Peginterferon Alfa-2a (Pegasys) in Treatment-Naive Participants With Advanced Liver Cancer

Phase 2 Completed

Gastrointestinal

Carcinoma, Hepatocellular

NCT00178763 2011-03-03

FR-WB-TT

Phase 2 Unknown

Gastrointestinal

Neoplasms, Pancreatic Neoplasms